# FDA recall D-0710-2018

> **Rhodes Pharmaceuticals, L.P.** · Class III · drug recall initiated 2018-04-17.

## Product

Aptensio XR (methylphenidate HCl extended-release) capsules 15 mg Rx Only 90-count bottle. Marketed by: Rhodes Pharmaceuticals L.P., Coventry, RI 02816. Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834. NDC 42858-402-45

## Reason for recall

Failed Dissolution Specification: Low dissolution outside of specifications

## Distribution

Nationwide within the USA

## Key facts

- **Recall number:** D-0710-2018
- **Recalling firm:** Rhodes Pharmaceuticals, L.P.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-04-17
- **Report date:** 2018-05-09
- **Termination date:** 2020-05-19

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Coventry, RI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0710-2018

## Citation

> AI Analytics. FDA recall D-0710-2018. Retrieved 2026-05-27 from https://api.ai-analytics.org/recall/D-0710-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*